Cargando…

Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting

OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Frisch, Barbara K, Slebocki, Karin, Mammadov, Kamal, Puesken, Michael, Becker, Ingrid, Maintz, David, Chang, De-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805212/
https://www.ncbi.nlm.nih.gov/pubmed/28587537
http://dx.doi.org/10.1177/0300060517712165
_version_ 1783298926899625984
author Frisch, Barbara K
Slebocki, Karin
Mammadov, Kamal
Puesken, Michael
Becker, Ingrid
Maintz, David
Chang, De-Hua
author_facet Frisch, Barbara K
Slebocki, Karin
Mammadov, Kamal
Puesken, Michael
Becker, Ingrid
Maintz, David
Chang, De-Hua
author_sort Frisch, Barbara K
collection PubMed
description OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT settings were 80 kVp with fixed exposure (20 mAs). Two radiologists evaluated image quality (i.e., needle artifacts, lesion contouring, vessel recognition, visibility of interlobar fissures). Complications and histological results were also evaluated. RESULTS: ULDCT was considered feasible for all lung interventions, showing the same diagnostic accuracy as SDCT. Its mean total radiation dose (dose–length product) was significantly reduced to 34 mGy-cm (SDCT 426 mGy-cm). Image quality and complication rates (P = 0.469) were consistent. CONCLUSIONS: ULDCT for CT-guided lung biopsies appears safe and accurate, with a significantly reduced radiation dose. We therefore recommend routine clinical use of ULDCT for the benefit of patients and interventionalists.
format Online
Article
Text
id pubmed-5805212
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58052122018-02-14 Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting Frisch, Barbara K Slebocki, Karin Mammadov, Kamal Puesken, Michael Becker, Ingrid Maintz, David Chang, De-Hua J Int Med Res Clinical Report OBJECTIVE: To evaluate the use of ultra-low-dose computed tomography (ULDCT) for CT-guided lung biopsy versus standard-dose CT (SDCT). METHODS: CT-guided lung biopsies from 115 patients (50 ULDCT, 65 SDCT) were analyzed retrospectively. SDCT settings were 120 kVp with automatic mAs modulation. ULDCT settings were 80 kVp with fixed exposure (20 mAs). Two radiologists evaluated image quality (i.e., needle artifacts, lesion contouring, vessel recognition, visibility of interlobar fissures). Complications and histological results were also evaluated. RESULTS: ULDCT was considered feasible for all lung interventions, showing the same diagnostic accuracy as SDCT. Its mean total radiation dose (dose–length product) was significantly reduced to 34 mGy-cm (SDCT 426 mGy-cm). Image quality and complication rates (P = 0.469) were consistent. CONCLUSIONS: ULDCT for CT-guided lung biopsies appears safe and accurate, with a significantly reduced radiation dose. We therefore recommend routine clinical use of ULDCT for the benefit of patients and interventionalists. SAGE Publications 2017-06-06 2017-12 /pmc/articles/PMC5805212/ /pubmed/28587537 http://dx.doi.org/10.1177/0300060517712165 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Report
Frisch, Barbara K
Slebocki, Karin
Mammadov, Kamal
Puesken, Michael
Becker, Ingrid
Maintz, David
Chang, De-Hua
Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title_full Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title_fullStr Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title_full_unstemmed Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title_short Implementation of ultra-low-dose lung protocols in CT-guided lung biopsies: feasibility and safety in the clinical setting
title_sort implementation of ultra-low-dose lung protocols in ct-guided lung biopsies: feasibility and safety in the clinical setting
topic Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805212/
https://www.ncbi.nlm.nih.gov/pubmed/28587537
http://dx.doi.org/10.1177/0300060517712165
work_keys_str_mv AT frischbarbarak implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT slebockikarin implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT mammadovkamal implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT pueskenmichael implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT beckeringrid implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT maintzdavid implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting
AT changdehua implementationofultralowdoselungprotocolsinctguidedlungbiopsiesfeasibilityandsafetyintheclinicalsetting